In acute decompensated HF, adding acetazolamide to IV loop diuretics reduced congestion at 3 d across eGFR levels
Annals of Internal Medicine · 2024
DOI: 10.7326/j23-0111 ↗Kurz gefasst
Kommentar in der Zeitschrift Annals of Internal Medicine, 2024. Verfasst von Daniel Rospert und 1 weiteren Autor:innen. Beteiligte Einrichtung: McGovern Medical School, UTHealth-University of Texas, Houston, Texas, USA (D.R., D.A.M.). Hauptthemen laut MEDLINE: Acetazolamide, Heart Failure.
Abstract (Originalsprache)
SOURCE CITATION: Meekers E, Dauw J, Martens P, et al. Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial. Eur Heart J. 2023;44:3672-3682. 37623428.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- McGovern Medical School, UTHealth-University of Texas, Houston, Texas, USA (D.R., D.A.M.).
Zitieren
APA
Rospert, D., & Molony, D. A. (2024). In acute decompensated HF, adding acetazolamide to IV loop diuretics reduced congestion at 3 d across eGFR levels. Annals of Internal Medicine. https://doi.org/10.7326/j23-0111
Vancouver
Rospert D, Molony DA. In acute decompensated HF, adding acetazolamide to IV loop diuretics reduced congestion at 3 d across eGFR levels. Annals of Internal Medicine. 2024. doi:10.7326/j23-0111
BibTeX
@article{Rospert2024,
author = {Rospert, Daniel and Molony, Donald A},
title = {In acute decompensated HF, adding acetazolamide to IV loop diuretics reduced congestion at 3 d across eGFR levels},
journal = {Annals of Internal Medicine},
year = {2024},
doi = {10.7326/j23-0111}
}
EUVIMED